Navigation Links
Freezor Xtra

ProductsFreezor Xtra
Company CryoCath Technologies, Inc.
Item Freezor Xtra
Features 
  • 7 French diameter
  • uni-directional catheter
  • 110cm working length
  • 6mm ablation electrode
  • 3 reaches (short, medium, long)
  • 4 mapping electrodes with 2-5-2 spacing
  • Description CryoCath has developed a minimally invasive cryocatheter to treat atrioventricular nodal reentrant tachycardia. It delivers a very high level of safety through accurate site confirmation, pinpoint site precision, minimal tissue disruption, and minimal risk of thrombus and stenosis.
    Freezor Xtra allows physicians to surgically treat cardiac arrhythmias in the pericardial space by minimally surgical techniques or during surgical cardiac procedures. It can be used in the subxyphoid approach to make lesions on the epicardial surface of the heart. In this procedure, the device is fed through a tiny incision just below the patient's sternum and advanced through an opening in the pericardial sac to reach the target epicardial location.
    CryoAblation is well suited in the pericardial space as this area has no blood flow. Thanks to CryoAdhesion, the device tip sticks to the epicardium during the ablation procedure, resulting in enhanced stability.
    Pre-clinical work has shown that Freezor Xtra is easily manipulated in the pericardial space and does not cause ay discernable damage to the coronary arteries when cryolesions are produced in close proximity to them.
    Info CryoCath Technologies, Inc.
    Customer Service: (877) 464-2796
    Web site: http://www.cryocath.com

    Related medicine products :

    1. Freezor 3
    2. Freezor 1
    3. Freezor 5
    4. Freezor MAX
    Breaking Medicine Technology:Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 2Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 3Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 4Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 5Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 6Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 7Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 8Reportlinker Adds Trauma Devices - Trends & Opportunities Worldwide 9Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 2Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 3Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 4Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 5Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 6Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 7Fast Forward LLC and Amplimmune Inc Join Forces to Speed New Treatments to People with MS 13684 1Fast Forward LLC and Amplimmune Inc Join Forces to Speed New Treatments to People with MS 13684 2Fast Forward LLC and Amplimmune Inc Join Forces to Speed New Treatments to People with MS 13684 3Fast Forward LLC and Amplimmune Inc Join Forces to Speed New Treatments to People with MS 13684 4New Survey Takes Important Step in Defining Comprehensive Spine Programs 55275 1New Survey Takes Important Step in Defining Comprehensive Spine Programs 55275 2Just in Time for Allergy Season ZYRTEC 28R 29 Provides New Solutions for Adults and Children 55272 1Just in Time for Allergy Season ZYRTEC 28R 29 Provides New Solutions for Adults and Children 55272 2Just in Time for Allergy Season ZYRTEC 28R 29 Provides New Solutions for Adults and Children 55272 3Just in Time for Allergy Season ZYRTEC 28R 29 Provides New Solutions for Adults and Children 55272 4